Novogenia GmbH, the core of the NOVOGENIA AG group, specialises in developing and applying advanced genetic diagnostic tests covering a wide range of health risks and lifestyle factors. Analysing genetic samples allows the company to give precise recommendations for disease prevention based on each customer’s individual genetic profile. Its services are aimed at customers who take a proactive approach to preventive healthcare and value tailored solutions.

The “Baby100” test is an outstanding example of its innovative diagnostic tools. By analysing metabolites in a baby’s urine, it can detect more than 100 genetic metabolic disorders that require early treatment to prevent serious harm. Tests of this precision can save lives, as they identify conditions that would otherwise often go undetected with severe consequences.

In addition to its medical services, Novogenia develops cosmetic products matched to users’ genetic characteristics. Each skin cream is individually blended and filled based on the customer’s specific genetic profile. These personalised products reflect the company’s commitment to innovation and tailored solutions beyond traditional healthcare.